Daily News Podcast

Alarming rate of diabetes medication discontinuations


 

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months. Also today, the FDA approves Ajovy for migraine prevention, some teens are using cannabis in their vapor devices, and alpha-blocker use is still common and still risky.


Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

New MI definition for infarction vs injury
MDedge Hematology and Oncology
Lung function decline linked to cardiovascular risk
MDedge Hematology and Oncology
Rivaroxaban beats aspirin for VTE
MDedge Hematology and Oncology
FDA approval for 2 HIV drugs
MDedge Hematology and Oncology
Modest alcohol and NAFLD
MDedge Hematology and Oncology
Cardiovascular risk with diclofenac
MDedge Hematology and Oncology
Baloxavir, oseltamivir similar for influenza
MDedge Hematology and Oncology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Hematology and Oncology
CDC opens Emergency Operations Center in advance of Hurricane Florence
MDedge Hematology and Oncology
Urine drug screens show improper medication use
MDedge Hematology and Oncology